Cargando…
New Candidates for Biomarkers and Drug Targets of Ischemic Stroke—A First Dynamic LC-MS Human Serum Proteomic Study
(1) Background: The aim of this dynamic-LC/MS-human-serum-proteomic-study was to identify potential proteins-candidates for biomarkers of acute ischemic stroke, their changes during acute phase of stroke and to define potential novel drug-targets. (2) Methods: A total of 32 patients (29–80 years) wi...
Autores principales: | Turek-Jakubowska, Aleksandra, Dębski, Janusz, Jakubowski, Maciej, Szahidewicz-Krupska, Ewa, Gawryś, Jakub, Gawryś, Karolina, Janus, Agnieszka, Trocha, Małgorzata, Doroszko, Adrian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8780942/ https://www.ncbi.nlm.nih.gov/pubmed/35054033 http://dx.doi.org/10.3390/jcm11020339 |
Ejemplares similares
-
Platelet-Derived Drug Targets and Biomarkers of Ischemic Stroke—The First Dynamic Human LC-MS Proteomic Study
por: Gawryś, Karolina, et al.
Publicado: (2022) -
Platelet Carbonic Anhydrase II, a Forgotten Enzyme, May Be Responsible for Aspirin Resistance
por: Jakubowski, M., et al.
Publicado: (2017) -
Interactions between the Cyclooxygenase Metabolic Pathway and the Renin-Angiotensin-Aldosterone Systems: Their Effect on Cardiovascular Risk, from Theory to the Clinical Practice
por: Gawrys, Jakub, et al.
Publicado: (2018) -
Intraplatelet L-Arginine-Nitric Oxide Metabolic Pathway: From Discovery to Clinical Implications in Prevention and Treatment of Cardiovascular Disorders
por: Gawrys, Jakub, et al.
Publicado: (2020) -
Novel Molecular Mechanisms of Pulmonary Hypertension: A Search for Biomarkers and Novel Drug Targets—From Bench to Bed Site
por: Gajecki, Damian, et al.
Publicado: (2020)